Occult hepatitis infection in transfusion medicine: screening policy and assessment of current use of anti-HBc testing
A Esposito, C Sabia, C Iannone, GF Nicoletti… - Transfusion Medicine …, 2017 - karger.com
HBV still represents a global risk factor in transfusion medicine. The residual risk of HBV is
not limited to pre-seroconversion window period but it extends to donors with occult HBV …
not limited to pre-seroconversion window period but it extends to donors with occult HBV …
Hepatitis B Virus DNA is absent in Lebanese blood donors who are positive for both anti-Hbc and anti-Hbs antibodies
G Kchour, M Fayyad-Kazan, A Haddad, B Badran… - Hepatitis …, 2017 - brieflands.com
Background: A major risk during blood transfusion is the transmission of infectious agents
such as Hepatitis B virus (HBV). Screening for anti-HBc antibodies has long been used to …
such as Hepatitis B virus (HBV). Screening for anti-HBc antibodies has long been used to …